NYSE · VTR
Ventas, Inc.
$83.71+$2.64 (+3.26%)
Ventas, Inc.’s quoted price sits in the lower half of its reported 52-week range, 17.61% below the high.
Loading market information…
NYSE · WELL · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Welltower Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.63% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Welltower Inc.’s forward annual dividend is $3.40 per share, paid quarterly. The forward yield is 1.46% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Welltower Inc.’s next earnings report is currently expected on Feb 9, 2027, with estimated earnings per share of $0.69. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Welltower Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Welltower Inc. (NYSE:WELL), an S&P 500 company based in Toledo, Ohio, is a leader in reshaping healthcare infrastructure. This Real Estate Investment Trust (REIT) strategically collaborates with premier operators in seniors housing, post-acute care, and health systems. Their core mission is to finance the vital property assets required to expand innovative care delivery models, thereby enhancing overall public wellness and healthcare experiences. Welltower's portfolio encompasses a variety of properties, including seniors housing, post-acute communities, and outpatient medical facilities, all situated primarily within key, rapidly growing markets across the United States, Canada, and the United Kingdom.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:23 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 |
|---|
| Jul 28, 2025 |
| $0.46+1.05% vs estimate |
| $2.55B+3.34% vs estimate |
| Q1 2025 | Apr 28, 2025 | $0.40-65.22% vs estimate | $2.42B+3.71% vs estimate |
|---|
| Q4 2024 | Feb 11, 2025 | $0.19-52.5% vs estimate | $2.25B+7.04% vs estimate |
|---|
THE ANALYST VIEW
37 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 13 contributors · Median target $260.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$83.71+$2.64 (+3.26%)
Ventas, Inc.’s quoted price sits in the lower half of its reported 52-week range, 17.61% below the high.
$46.84+$1.20 (+2.63%)
Omega Healthcare Investors, Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.59% below the high.
$18.94+$0.39 (+2.1%)
Healthpeak Properties, Inc.’s quoted price sits in the lower half of its reported 52-week range, 17.47% below the high.
$52.94+$1.44 (+2.8%)
American Healthcare REIT, Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.81% below the high.
$36.26+$0.81 (+2.28%)
CareTrust REIT, Inc.’s quoted price sits in the lower half of its reported 52-week range, 16.87% below the high.
$19.61+$0.54 (+2.83%)
Sabra Health Care REIT, Inc.’s quoted price sits in the lower half of its reported 52-week range, 13.88% below the high.
$66.95+$1.27 (+1.93%)
National Health Investors, Inc.’s quoted price sits in the lower half of its reported 52-week range, 26.73% below the high.
$44.32+$1.59 (+3.72%)
LTC Properties, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
